Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya

References

1. 1.↵
   2. Lin N,
   3. Smith ER,
   4. Scott RM, et al

   . Safety of neuroangiography and embolization in children: complication analysis of 697 consecutive procedures in 394 patients. J Neurosurg Pediatr 2015;16:432–38 doi:10.3171/2015.2.PEDS14431 pmid:26114994

   CrossRefPubMed
2. 2.↵
   2. Robertson RL,
   3. Chavali RV,
   4. Robson CD, et al

   . Neurologic complications of cerebral angiography in childhood moyamoya syndrome. Pediatr Radiol 1998;28:824–29 doi:10.1007/s002470050474 pmid:9799310

   CrossRefPubMed
3. 3.↵
   2. Calamante F,
   3. Ganesan V,
   4. Kirkham FJ, et al

   . MR perfusion imaging in moyamoya syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 2001;32:2810–16 doi:10.1161/hs1201.099893 pmid:11739978

   Abstract/FREE Full Text
4. 4.↵
   2. Zaharchuk G,
   3. Do HM,
   4. Marks MP, et al

   . Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya. Stroke 2011;42:2485–91 doi:10.1161/STROKEAHA.111.616466 pmid:21799169

   Abstract/FREE Full Text
5. 5.↵
   2. Wong EC,
   3. Cronin M,
   4. Wu WC, et al

   . Velocity-selective arterial spin labeling. Magn Reson Med 2006;55:1334–41 pmid:16700025

   PubMed
6. 6.↵
   2. Qiu D,
   3. Straka M,
   4. Zun Z, et al

   . CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: comparison with xenon CT CBF. J Magn Reson Imaging 2012;36:110–19 doi:10.1002/jmri.23613 pmid:22359345

   CrossRefPubMed
7. 7.↵
   US Food and Drug Administration. Xenon Xe 133 Gas. Washington, DC: US Food and Drug Administration; 2016 https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018327s005lbl.pdf. Accessed December 26, 2016
8. 8.↵
   2. Wu W,
   3. Wong E

   . Intravascular effect in velocity-selective arterial spin labeling. Conf Proc IEEE Eng Med Biol Soc 2005;6:5790–93 pmid:17281574

   PubMed
9. 9.↵
   2. Alsop DC,
   3. Detre JA,
   4. Golay X, et al

   . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

   CrossRefPubMed
10. 10.↵
    2. Buxton RB,
    3. Frank LR,
    4. Wong EC, et al

    . A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383–96 doi:10.1002/mrm.1910400308 pmid:9727941

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Cavusoglu M,
    3. Pfeuffer J,
    4. Uğurbil K, et al

    . Comparison of pulsed arterial spin labeling encoding schemes and absolute perfusion quantification. Magn Reson Imaging 2009;27:1039–45 doi:10.1016/j.mri.2009.04.002 pmid:19540694

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Kim JJ,
    3. Fischbein NJ,
    4. Lu Y, et al

    . Regional angiographic grading system for collateral flow: correlation with cerebral infarction in patients with middle cerebral artery occlusion. Stroke 2004;35:1340–44 doi:10.1161/01.STR.0000126043.83777.3a pmid:15087564

    Abstract/FREE Full Text
13. 13.↵
    2. Fonov V,
    3. Evans AC,
    4. Botteron K, et al

    . Unbiased average age-appropriate atlases for pediatric studies. Neuroimage 2011;54:313–27 doi:10.1016/j.neuroimage.2010.07.033 pmid:20656036

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Mutsaerts HJ,
    3. van Dalen JW,
    4. Heijtel DF, et al

    . Cerebral perfusion measurements in elderly with hypertension using arterial spin labeling. PLoS One 2015;10:e0133717 doi:10.1371/journal.pone.0133717 pmid:26241897

    CrossRefPubMed
15. 15.↵
    2. Tatu L,
    3. Moulin T,
    4. Bogousslavsky J, et al

    . Arterial territories of the human brain: cerebral hemispheres. Neurology 1998;50:1699–1708 doi:10.1212/wnl.50.6.1699 pmid:9633714

    Abstract/FREE Full Text
16. 16.↵
    2. Biagi L,
    3. Abbruzzese A,
    4. Bianchi MC, et al

    . Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J Magn Reson Imaging 2007;25:696–702 doi:10.1002/jmri.20839 pmid:17279531

    CrossRefPubMed
17. 17.↵
    2. Wang J,
    3. Licht DJ

    . Pediatric perfusion MR imaging using arterial spin labeling. Neuroimaging Clin N Am 2006;16:149–67, ix doi:10.1016/j.nic.2005.10.002 pmid:16543090

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Detre JA,
    3. Samuels OB,
    4. Alsop DC, et al

    . Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging 1999;10:870–75 doi:10.1002/(SICI)1522-2586(199911)10:5<870::AID-JMRI36>3.0.CO;2-D pmid:10548801

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Zaharchuk G

    . Arterial spin label imaging of acute ischemic stroke and transient ischemic attack. Neuroimaging Clin N Am 2011;21:285–301, x doi:10.1016/j.nic.2011.01.003 pmid:21640300

    CrossRefPubMed
20. 20.↵
    2. Deibler AR,
    3. Pollock JM,
    4. Kraft RA, et al

    . Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228–34 doi:10.3174/ajnr.A1030 pmid:18372417

    Abstract/FREE Full Text
21. 21.↵
    2. Mutke MA,
    3. Madai VI,
    4. von Samson-Himmelstjerna FC, et al

    . Clinical evaluation of an arterial-spin-labeling product sequence in steno-occlusive disease of the brain. PLoS One 2014;9:e87143 doi:10.1371/journal.pone.0087143 pmid:24516546

    CrossRefPubMed
22. 22.↵
    2. Schmid S,
    3. Heijtel DF,
    4. Mutsaerts HJ, et al

    . Comparison of velocity- and acceleration-selective arterial spin labeling with [15O]H2O positron emission tomography. J Cereb Blood Flow Metab 2015;35:1296–1303 doi:10.1038/jcbfm.2015.42 pmid:25785831

    CrossRefPubMed
23. 23.↵
    2. Wang J,
    3. Licht DJ,
    4. Jahng G-H, et al

    . Pediatric perfusion imaging using pulsed arterial spin labeling. J Magn Reson Imaging 2003;18:404–13 doi:10.1002/jmri.10372 pmid:14508776

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Ishii R,
    3. Takeuchi S,
    4. Ibayashi K, et al

    . Intelligence in children with moyamoya: evaluation after surgical treatments with special reference to changes in cerebral blood flow. Stroke 1984;15:873–77 doi:10.1161/01.str.15.5.873 pmid:6474539

    Abstract/FREE Full Text
25. 25.↵
    2. McAuley DJ,
    3. Poskitt K,
    4. Steinbok P

    . Predicting stroke risk in pediatric moyamoya with xenon-enhanced computed tomography. Neurosurgery 2004;55:327–32; discussion 332–33 doi:10.1227/01.NEU.0000129695.91536.41 pmid:15271238

    CrossRefPubMed
26. 26.↵
    2. Touho H,
    3. Karasawa J,
    4. Ohnishi H

    . Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood moyamoya. Stroke 1996;27:282–289 doi:10.1161/01.str.27.2.282 pmid:8571424

    Abstract/FREE Full Text
27. 27.↵
    2. Lee M,
    3. Zaharchuk G,
    4. Guzman R, et al

    . Quantitative hemodynamic studies in moyamoya: a review. Neurosurg Focus 2009;26:E5 doi:10.3171/2009.1.FOCUS08300 pmid:19335131

    CrossRefPubMed
28. 28.↵
    2. Ikezaki K,
    3. Matsushima T,
    4. Kuwabara Y, et al

    . Cerebral circulation and oxygen metabolism in childhood moyamoya: a perioperative positron emission tomography study. J Neurosurg 1994;81:843–50 doi:10.3171/jns.1994.81.6.0843 pmid:7965114

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Bolar DS,
    3. Rosen BR,
    4. Schaefer PW

    . Comparison of Velocity-selective and Pulsed ASL Perfusion MRI in Patients with Suspected Cerebral Cortical Ischemia. In: Proceedings of the Annual Meeting of American Society of Neuroradiology, Vancouver, BC. June 6, 2018:1–4
30. 30.↵
    2. Wu B,
    3. Wang X,
    4. Guo J, et al

    . Collateral circulation imaging: MR perfusion territory arterial spin-labeling at 3T. AJNR Am J Neuroradiol 2008;29:1855–60 doi:10.3174/ajnr.A1259 pmid:18784211

    Abstract/FREE Full Text
31. 31.↵
    2. Fan AP,
    3. Guo J,
    4. Khalighi MM, et al

    . Long-delay arterial spin labeling provides more accurate cerebral blood flow measurements in moyamoya patients: a simultaneous positron emission tomography/MRI study. Stroke 2017;48:2441–49 doi:10.1161/STROKEAHA.117.017773 pmid:28765286

    Abstract/FREE Full Text
32. 32.↵
    2. So Y,
    3. Lee H-Y,
    4. Kim SK, et al

    . Prediction of the clinical outcome of pediatric moyamoya with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke 2005;36:1485–89 doi:10.1161/01.STR.0000170709.95185.b1 pmid:15947261

    Abstract/FREE Full Text
33. 33.↵
    2. Yun TJ,
    3. Paeng JC,
    4. Sohn C-H, et al

    . Monitoring cerebrovascular reactivity through the use of arterial spin labeling in patients with moyamoya. Radiology 2016;278:205–13 doi:10.1148/radiol.2015141865 pmid:26197057

    CrossRefPubMed
34. 34.↵
    2. Blauwblomme T,
    3. Lemaitre H,
    4. Naggara O, et al

    . Cerebral blood flow improvement after indirect revascularization for pediatric moyamoya: a statistical analysis of arterial spin-labeling MRI. AJNR Am J Neuroradiol 2016;37:706–12 doi:10.3174/ajnr.A4592 pmid:26585258

    Abstract/FREE Full Text
35. 35.↵
    2. Wu WC,
    3. Wong EC

    . Feasibility of velocity selective arterial spin labeling in functional MRI. J Cereb Blood Flow Metab 2007;27:831–38 doi:10.1038/sj.jcbfm.9600386 pmid:16926843

    CrossRefPubMed
36. 36.↵
    2. Wu WC,
    3. Wong EC

    . Intravascular effect in velocity-selective arterial spin labeling: the choice of inflow time and cutoff velocity. Neuroimage 2006;32:122–28 doi:10.1016/j.neuroimage.2006.03.001 pmid:16713716

    CrossRefPubMedWeb of Science
37. 37.
    2. Suzuki J,
    3. Takaku A

    . Cerebrovascular “moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99 doi:10.1001/archneur.1969.00480090076012 pmid:5775283

    CrossRefPubMedWeb of Science
38. 38.
    2. Matsushima T,
    3. Inoue T,
    4. Suzuki SO, et al

    . Surgical treatment of moyamoya disease in pediatric patients: comparison between the results of indirect and direct revascularization procedures. Neurosurgery 1992;31:401–05 doi:10.1227/00006123-199209000-00003 pmid:1407421

    CrossRefPubMedWeb of Science